Journal Article
|ResearchThe drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment
Abstract
In 1975-99, only 1·1% of new therapeutic products had been developed for neglected diseases. Since then, several public and private initiatives have attempted to mitigate this imbalance. We analysed the research and development pipeline of drugs and vaccines for neglected diseases from 2000 to 2011.
Subject Area
Languages
English